{"id":"NCT02260791","sponsor":"Fujifilm Kyowa Kirin Biologics Co., Ltd.","briefTitle":"A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients","officialTitle":"A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12","primaryCompletion":"2016-07","completion":"2016-07","firstPosted":"2014-10-09","resultsPosted":"2017-09-20","lastUpdate":"2017-11-28"},"enrollment":728,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Arthritis, Rheumatoid"],"interventions":[{"type":"DRUG","name":"FKB327","otherNames":[]},{"type":"DRUG","name":"Humira®","otherNames":[]}],"arms":[{"label":"FKB327","type":"EXPERIMENTAL"},{"label":"Humira®","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to compare the effectiveness and safety of FKB327 in comparison to Humira® in rheumatoid arthritis patients who have inadequate disease control on methotrexate.","primaryOutcome":{"measure":"American College of Rheumatology (ACR) 20 Response Rate","timeFrame":"Week 24","effectByArm":[{"arm":"FKB327","deltaMin":72.5,"sd":null},{"arm":"Humira®","deltaMin":74.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":100,"countries":["United States","Bulgaria","Canada","Chile","Czechia","Germany","Peru","Poland","Romania","Russia","Spain","Ukraine"]},"refs":{"pmids":["33263165","31831079"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":366},"commonTop":["Nasopharyngitis"]}}